The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.
about
Turning science into health solutions: KEMRI's challenges as Kenya's health product pathfinder.Mentoring, training and support to global health innovators: a scoping review.New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?A Disruptive Innovation Model for Indigenous Medicine Research: A Nigerian Perspective
P2860
The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The road to commercialization ...... the sickle-cell drug Niprisan.
@ast
The road to commercialization ...... the sickle-cell drug Niprisan.
@en
The road to commercialization ...... the sickle-cell drug Niprisan.
@nl
type
label
The road to commercialization ...... the sickle-cell drug Niprisan.
@ast
The road to commercialization ...... the sickle-cell drug Niprisan.
@en
The road to commercialization ...... the sickle-cell drug Niprisan.
@nl
prefLabel
The road to commercialization ...... the sickle-cell drug Niprisan.
@ast
The road to commercialization ...... the sickle-cell drug Niprisan.
@en
The road to commercialization ...... the sickle-cell drug Niprisan.
@nl
P2093
P2860
P1476
The road to commercialization ...... the sickle-cell drug Niprisan.
@en
P2093
Abdallah S Daar
Andrew Kapoor
Hassan Masum
Kumar Perampaladas
Peter A Singer
Ronak Shah
P2860
P2888
P356
10.1186/1472-698X-10-S1-S11
P478
10 Suppl 1
P577
2010-12-13T00:00:00Z
P6179
1019433376